Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike

September 4, 2016

Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

epipen alternative
Mark Baum / Imprimis Pharmceuticals

Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.

"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.

"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."


feel good videoDogs Are Forced To Wear The Things They Steal — And It’s Hilarious

feel good storiesKitties for Sale: How to Choose a Healthy, Happy Kitten

feel good stories25 Unforgettable Things to Do in Chicago

feel good storiesSmall Acts of Kindness That Change a Stranger’s Entire Day

feel good storiesA Man Thanked the Voice of Mario for His Childhood. Charles Martinet’s Response Was Beautiful

feel good storiesConstruction Crew Rescues Kitten From Excavator, Then Gives Her a Job

feel good videoTwo Goats Escape Their Yard and Decide to Catch the Morning Bus

feel good videoMeet Otter, the Kitten in the Tiny Helmet

feel good videoSingle Dad Adopts Girl with Down Syndrome

feel good videoThis Dog Was Banned From a Store for Stealing. The Day He Returned, He Stole Again

feel good videoThese Tiny Birds Look So Angry, It's Adorable